Mabpharm Limited (HKG:2181)

Mabpharm Revenue

Mabpharm had revenue of 397.94M CNY in the half year ending June 30, 2026, with 266.82% growth. This brings the company's revenue in the last twelve months to 769.85M, up 81.60% year-over-year. In the year 2025, Mabpharm had annual revenue of 646.10M with 150.20% growth.

• Revenue (ttm): 769.85M CNY
• Revenue Growth: +81.60%
• P/S Ratio: 1.81
• Revenue / Employee: 1.95M CNY
• Employees: 394
• Market Cap: 1.61B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	646.10M	387.87M	150.20%
Dec 31, 2024	258.23M	171.07M	196.27%
Dec 31, 2023	87.16M	31.24M	55.87%
Dec 31, 2022	55.92M	-26.96M	-32.53%
Dec 31, 2021	82.88M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error